Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000077

EVP, Chf Clinical Develop Ofcr sold 5,482 shares at $50.42 ($276,386)

  • EVP, Chf Clinical Develop Ofcr acquired 15,162 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schneider Eugene · EVP, Chf Clinical Develop Ofcr

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-16 Exercise or conversion : show line 1 in the form +15,162 53,332 D
2024-01-17 Sale : show line 2 in the form −5,482 $50.42 $276,386 47,850 D
Open-market sales · 5,482 sh · avg $50.42 · $276,386

Table II: Derivative

1 line
Date Transaction Shares Exercise Underlying Owned after D/I
2024-01-16 Exercise or conversion : show line 3 in the form Restricted Stock Unit −15,162 $0.00 15,162 45,308 D
Loading xslF345X05/edgardoc.xml…